References
- Carrel A. The transplantation of veins and organs. Am J Med. 1905;11:1101-1106.
- Konstantinov IE. At the cutting edge of the impossible: a tribute to Vladimir P. Demikhov. Tex Heart Inst J. 2009;36(5):453-8. PMID: 19876428
- Golberg M, Berman EF, Akman LC. Homologous transplantation of the canine heart. J Int Coll Surg. 1958 Nov;30(5 Part 1):575-86. PMID: 13611305
- Webb WR, Howard HS, Neely WA. Practical methods of homologous cardiac transplantation. J Thorac Surg. 1959 Mar;37(3):361-6. PMID: 13631727
- Cass MH, Brock R. Heart excision and replacement. Guys Hosp Rep. 1959;108:285-90. PMID: 13808190
- Hardy JD, Chavez CM, Kurrus FD, et al. Heart Transplantation in Man: Developmental Studies and Report of a Case. JAMA. 1964;188(13):1132-1140. doi: 10.1001/jama.1964.03060390034008
- Kondo Y, Grädel F, Kantrowitz A. Homotransplantation of the Heart in Puppies Under Profound Hypothermia: Long Survival Without Immunosuppressive Treatment. Ann Surg. 1965 Nov;162(5):837-48. doi: 10.1097/00000658-196511000-00005
- Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967 Dec 30;41(48):1271-4. PMID: 4170370
- Tan SY, Linskey K. Christiaan Barnard (1922-2001): First heart transplant surgeon. Singapore Med J. 2019 Oct;60(10):495-496. doi: 10.11622/smedj.2019127
- Najarian JS. Norman E. Shumway, MD, PhD (1923-2006). Clin Transplant. 2006 May-Jun;20(3):269-71. doi: 10.1111/j.1399-0012.2006.00526.x
- Yang X, Feng P, Yin Y, Bushley K, Spatafora JW, Wang C. Cyclosporine Biosynthesis in Tolypocladium inflatum Benefits Fungal Adaptation to the Environment. mBio. 2018 Oct 2;9(5). doi: 10.1128/mBio.01211-18
- Barnard CN, Losman JG. Left ventricular bypass. S Afr Med J. 1975 Mar 1;49(9):303-12. PMID: 1090016
- Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy. 2021 Jan;41(1):119-131. doi: 10.1002/phar.2481
- Guada M, Beloqui A, Kumar MNVR, Préat V, Dios-Viéitez MdC, Blanco-Prieto MJ. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy. J Control Release. 2016 Mar 10;225:269-82. doi: 10.1016/j.jconrel.2016.01.056
- Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-Human Cardiac Xenotransplantation in a Neonate. JAMA. 1985;254(23):3321-3329. doi: 10.1001/jama.1985.03360230053022
- Balk AH, Zondervan PE, van der Meer P, et al. Effect of adopting a new histological grading system of acute rejection after heart transplantation. Heart. 1997 Dec;78(6):603-7. doi: 10.1136/hrt.78.6.603
- FDA [Internet]. Silver Spring, MD: US Food and Drug Administration; c2025.
Prograf tacrolimus capsuls ; 2006 Apr [cited 2025 Apr 14]. Available from:https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050708s026,050709s020lbl.pdf - Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology. 2000 May 1;47(2):215-245. doi: 10.1016/S0162-3109(00)00190-9
- Eisen HJ, Hobbs RE, Davis SF, et al. Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine—results at 24 months after transplantation. Transplantation. 2001 Jan 15;71(1):70-8. doi: 10.1097/00007890-200101150-00012
- Alloway RR, Woodle ES, Abramowicz D, et al. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation. Am J Transplant. 2019 Aug;19(8):2252-2261. doi: 10.1111/ajt.15342
- FDA [Internet]. Silver Spring, MD: US Food and Drug Administration; c2025.
Rapamune (sirolimus) ; 1999 Sep 15 [cited 2025 Apr 14]. Available from:https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021110s058lbl.pdf - Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients. New Engl J Med. 2003 Aug;349(9):847-858. doi: 10.1056/NEJMoa022171
- Chauhan K, Mehta AA. Rituximab in kidney disease and transplant. Animal Model Exp Med. 2019 Mar 26;2(2):76-82. doi: 10.1002/ame2.12064
- Ravichandran AK, Schilling JD, Novak E, Pfeifer J, Ewald GA, Joseph SM. Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review. Clin Transplant. 2013 Nov-Dec;27(6):961-7. doi: 10.1111/ctr.12277
- Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005 Nov;24(11):1710-20. doi: 10.1016/j.healun.2005.03.019
- Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation. 2008 Dec 27;86(12):1754-61. doi: 10.1097/TP.0b013e318190af83
- CMS [Internet]. Baltimre, MD: Centers for Medicare and Medicaid Services;
c2025 AlloMap Molecular Expression Testing for Detection of Rejection of Cardiac Allografts ; 2020 Dec 11 [cited 2025 Apr 14]. Available from:https://www.cms.gov/medicare-coverage-database/view/ncacal-public-comments.aspx?NCAId=302 - Patel J, Dilibero D, Kittleson M, et al. The Use of Eculizumab to Treat the Highly Sensitized Patient Awaiting Heart Transplant. Am J Transplant. 2015 May 4;15(suppl 3). Available from:
https://atcmeetingabstracts.com/abstract/the-use-of-eculizumab-to-treat-the-highly-sensitized-patient-awaiting-heart-transplant/ - Thrush PT, Pahl E, Naftel DC, et al. A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes. J Heart Lung Transplant. 2016 Dec;35(12):1497-1504. doi: 10.1016/j.healun.2016.06.014
- FDA [Internet]. Silver Spring, MD: US Food and Drug Administration; c2025.
510(k) premarket notification- Paragonix SherpaPak Cardiac Transport System ; 2014 Feb 21 [cited 2025 Apr 14]. Available from:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K133432 - Messer S, Page A, Axell R, et al. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2017 Dec;36(12):1311-1318. doi: 10.1016/j.healun.2017.10.021
- Halloran PF, Famulski KS, Reeve J. Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol. 2016 Sep;12(9):534-48. doi: 10.1038/nrneph.2016.85
- Halloran P, Kim D, Loupy A, et al. Development and Validation of a Molecular Microscope Diagnostic System (MMDx) for Heart Transplant Biopsies. Am J Transplant. 2016;16(suppl 3). Available from:
https://atcmeetingabstracts.com/abstract/development-and-validation-of-a-molecular-microscope-diagnostic-system-mmdx-for-heart-transplant-biopsies/ - Bloom RD, Bromberg JS, Poggio ED, et al. Cell-Free DNA and Active Rejection in Kidney Allografts. J Am Soc Nephrol. 2017 Jul;28(7):2221-2232. doi: 10.1681/asn.2016091034
- Paragonix [Internet]. Waltham, MA: Paragonix Technologies; c2025.
Paragonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports ; 2021 Nov 15 [cited 2025 Apr 14]. Available from:https://www.paragonixtechnologies.com/news/paragonix-technologies-announces-milestone-of-1-000-preserved-donor-heart-transports - Fernández-Gallardo M, Corzo-Lopez A, Muñoz-Herrera D, et al. Role of the Ca2+ channel α2δ-1 auxiliary subunit in proliferation and migration of human glioblastoma cells. PLoS One. 2022 Dec 15;17(12):
e0279186 . doi: 10.1371/journal.pone.0279186 - FDA [Internet]. Silver Spring, MD: US Food and Drug Administration; c2025.
premarket Approval (PMA) – TransMedics Organ Care System (OCS) Heart System ; 2021 Sep 3 [cited 2025 Apr 14]. Available from:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P180051 - Hawthorne WJ. World first pig-to-human cardiac xenotransplantation. Xenotransplantation. 2022 Jan;29(1):
e12733 . doi: 10.1111/xen.12733 - Langer RM. Vladimir P. Demikhov, a pioneer of organ transplantation. Transplant Proc. 2011 May;43(4):1221-2. doi: 10.1016/j.transproceed.2011.03.070
- Webb WR, Howard HS, Neely WA. Practical methods of homologous cardiac transplantation. J Thorac Surg. 1959 Mar;37(3):361-6. PMID: 13631727
- Golberg M, Berman EF, Akman LC. Homologous transplantation of the canine heart. J Int Coll Surg. 1958 Nov;30(5 Part 1):575-86. PMID: 13611305
- Cass MH, Brock R. Heart excision and replacement. Guys Hosp Rep. 1959;108:285-290. PMID: 13808190
- Reemtsma K. THE HEART AS A TEST ORGAN IN TRANSPLANTATION STUDIES. Ann N Y Acad Sci. 1964 Nov 30;120(1):778-85. doi: 10.1111/j.1749-6632.1964.tb34769.x
- Reemtsma K, Williamson WE
Jr. , Iglesias F, Pena E, Sayegh SF, Creech OJr. . Studies in homologous canine heart transplantation:prolongation of survival with a folic acid antagonist. Surgery. 1962 Jul;52:127-33. PMID: 14490981 - Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 1960;11:18-19. PMID: 13763847
- Cooper DK. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent). 2012 Jan;25(1):49-57. doi: 10.1080/08998280.2012.11928783
- Hardy JD, Chavez CM, Kurrus FD, et al. Heart Transplantation in Man: Developmental Studies and Report of a Case. JAMA. 1964 Jun 29;188(13):1132-1140. PMID: 14163110
- Boulet J, Cunningham JW, Mehra MR. Cardiac Xenotransplantation: Challenges, Evolution, and Advances. JACC: Basic Transl Sci. 2022 Jun 15;7(7):716-729. doi: 10.1016/j.jacbts.2022.05.003
- Cooper DKC. Christiaan Barnard-The surgeon who dared: The story of the first human-to-human heart transplant. Glob Cardiol Sci Pract. 2018 Jun 30;2018(2):11. doi: 10.21542/gcsp.2018.11
- Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967 Dec 30;41(48):1271-4. PMID: 4170370
- Brink JG, Hassoulas J. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town – with reference to : the operation. A human cardiac transplant : an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. Cardiovasc J Afr. 2009 Jan-Feb;20(1):31-35. PMID: 19287813
- Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 years of Clinical Heart Transplantation in Circulation: In-Depth State-of the-Art Review. Circulation. 2018 Jan 2;137(1):71-87. doi: 10.1161/CIRCULATIONAHA.117.029753
- Wilhelm MJ, Ruschitzka F, Flammer AJ, Bettex D, Turina MI, Maisano F. Fiftieth anniversary of the first heart transplantation in Switzerland in the context of the worldwide history of heart transplantation. Swiss Med Wkly. 2020 Feb 7;150:w20192. doi: 10.4414/smw.2020.20192
- Borel JF, Kis ZL, Beveridge T, authors.
The History of the Discovery and Development of Cyclosporine (Sandimmune®) . In: Merluzzi VJ, Adams J, editors. The Search for Anti-Inflammatory Drugs. Switzerland: Birkhäuser Boston; 1995. - Jamieson SW, Burton NA, Bieber CP, et al. Survival of cardiac allografts in rats treated with cyclosporin A. Surg Forum. 1979;30:289-291. PMID: 395684
- Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Eight-year results of cyclosporine-treated patients with cardiac transplants. J Thorac Cardiovasc Surg. 1990 Mar;99(3):500-509. PMID: 2308368
- Sivathasan C. Experience with cyclosporine in heart transplantation. Transplant Proc. 2004 Mar;36(2 Suppl):S346-S348. doi: 10.1016/j.transproceed.2004.01.072
- Patel JK, Kobashigawa JA. Cardiac transplant experience with cyclosporine. Transplant Proc. 2004 Mar;36(2, Suppl):S323-S330. doi: 10.1016/j.transproceed.2004.01.039
- McCormack PL, Keating GM. Tacrolimus: in heart transplant recipients. Drugs. 2006;66(17):2269-2279; discussion 2280-2262. doi: 10.2165/00003495-200666170-00010
- Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant. 1999 Apr;18(4):336-45. doi: 10.1016/s1053-2498(98)00060-6
- Kobashigawa JA, Patel J, Furukawa H, et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant. 2006 Apr;25(4):434-9. doi: 10.1016/j.healun.2005.11.452
- Curtis A, Guha A, Bhimaraj A, et al. Use of Daratumumab for Desensitization Prior to Cardiac Transplantation: A Case Report. J Heart Lung Transplant. 2021 Apr;40(4 Suppl):S493. doi: 10.1016/j.healun.2021.01.2015
- Fida N, Eagar TN, Yun AN, et al. Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 Feb;38(2):
e15249 . doi: 10.1111/ctr.15249. - Caves PK, Stinson EB, Billingham M, Shumway NE. Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg. 1973 Oct;16(4):325-36. doi: 10.1016/s0003-4975(10)65002-3
- Crespo-Leiro MG, Stypmann J, Schulz U, et al. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J. 2016 Sep 1;37(33):2591-601. doi: 10.1093/eurheartj/ehv682
- Kobashigawa J, Patel J, Azarbal B, et al. Randomized Pilot Trial of Gene Expression Profiling Versus Heart Biopsy in the First year After Heart Transplant. Circ Heart Fail. 2015 May;8(3):557-64. doi: 10.1161/CIRCHEARTFAILURE.114.001658
- Halloran PF, Madill-Thomsen KS. The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies. Transplantation. 2023 Jan 1;107(1):27-44. doi: 10.1097/TP.0000000000004323
- Agbor-Enoh S, Shah P, Tunc I, et al. Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation. 2021 May 23;143(12):1184-1197. doi: 10.1161/CIRCULATIONAHA.120.049098
- Borkowski P, Singh N, Borkowska N. Advancements in Heart Transplantation: Donor-Derived Cell-Free DNA as Next-Generation Biomarker. Cureus. 2024 Feb 11;16(2):
e54018 . doi: 10.7759/cureus.54018 - Keller M, Agbor-Enoh S. Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation. Curr Transplant Rep. 2021;8(4):351-358. doi: 10.1007/s40472-021-00349-8
- Barboza AB, Dhanani NH, Browning K, Wood RP, Hall DR. Trends in donation after circulatory determination of death donor utilization: Lessons from Houston. Transplant Reports. 2023 Apr 11;8(2):100135. doi: 10.1016/j.tpr.2023.100135
- Messer S, Page A, Axell R, et al. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2017 Dec;36(12):1311-1318. doi: 10.1016/j.healun.2017.10.021
- Jia S, Caranasos TG, Kumar PA. Pro: Advantages of Using TransMedics Organ Care System Heart in Heart Transplantation. J Cardiothorac Vasc Anesth. 2024 Feb;38(2):569-572. doi: 10.1053/j.jvca.2023.11.005
- Voigt JD, Leacche M, Copeland H, et al. Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients. ASAIO J. 2023 Apr 1;69(4):345-349. doi: 10.1097/MAT.0000000000001844
DOI: https://doi.org/10.14797/mdcvj.1579 | Journal eISSN: 1947-6108
Language: English
Page range: 5 - 12
Submitted on: Feb 4, 2025
Accepted on: Apr 1, 2025
Published on: May 15, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2025 Farhan Ishaq, Ashrith Guha, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.